Wuxi Advanced Therapies And A*Star Announce Partnership To Advance Cell And Gene Therapy In The Asia-Pacific RegionWuxi Advanced Therapies And A*Star Announce Partnership To Advance Cell And Gene Therapy In The Asia-Pacific RegionWuxi Advanced Therapies, A Wholly Owned Subsidiary Of Wuxi Apptec, And A*Star'S Bioprocessing Technology Institute (Bti), Has Announced A New Partnership To Bring Wuxi Atu'S Proprietary Tetracycline-Enabled Self-Silencing Adenovirus (Tessa
